Related Experiment Videos
Information on antineoplastic drugs for nononcologist physicians
American Journal of Hospital Pharmacy
|August 1, 1977
Summary
Physicians found drug information letters helpful for chemotherapy administration, particularly for investigational drugs. The positive feedback supports expanding this vital communication service for healthcare providers.
Area of Science:
- Oncology
- Clinical Pharmacy
- Healthcare Communication
Background:
- Physicians administering injectable chemotherapy to outpatients require timely and accurate drug information.
- Effective communication of drug data, including side effects, administration routes, and stability, is crucial for patient safety and treatment efficacy.
- Existing drug information services may not fully meet the needs of healthcare providers in specialized fields like oncology.
Purpose of the Study:
- To evaluate the effectiveness and physician perception of drug information letters sent to healthcare providers administering injectable chemotherapy.
- To assess the utility of drug information letters for both investigational and commercially available chemotherapy agents.
- To identify specific drug classes and physician groups that benefit most from the distributed drug information.
Main Methods:
- A postcard questionnaire was distributed to physicians administering injectable chemotherapy to outpatients over an eight-month period.
- The questionnaire assessed physician awareness of drug side effects, administration routes, and stability, as well as the overall helpfulness of the provided information.
- Data analysis focused on response rates, drug types, and differences in perceived helpfulness between oncologists and non-oncologists.
Main Results:
- A 30% return rate (86 of 282 questionnaires) was achieved, with doxorubicin, fluorouracil, and cyclophosphamide being the most frequently reported drugs.
- Physician knowledge of drug administration routes (86%) and side effects (76%) was high, while knowledge of stability (66%) was lower.
- Over 90% of physicians found the information helpful for both investigational and commercially available drugs, with non-oncologists (98%) reporting higher helpfulness than oncologists (66%).
Conclusions:
- Drug information letters are a valuable tool for enhancing physician knowledge and supporting safe chemotherapy administration.
- The program demonstrated significant positive physician engagement, particularly for investigational agents and among non-oncologists.
- Expansion of the drug information service is recommended based on the positive reception and perceived utility by healthcare providers.